Certified by Founder Lodge 
                                        
                                        QurAlis
 
                                                 United States  -  Cambridge, MA 
                                             START UP 
                                                                                    1 Disclosed Funding Rounds $88,000,000
                                            0 Participating Investments
- 
                                                Founded date 
                                                
2016
 - 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. We are digging deep into the root causes of the
                                        
                                        
                                        
                                                                                
                                        
                                                                                | Date | Round | Raised | Participating Investors | 
|---|---|---|---|
| March, 10 ,2023 | Series B | $88,000,000 | 
                                                
 Dolby Family Ventures
                                                                                
 EQT Life Sciences
                                                                                
                                                                            
 Inkef
                                                                                
 Droia Ventures
                                                                                
                                                                            
 Mission Bay Capital
                                                                                
 Mitsui & Co. Global Investment Ltd.
                                                                                
                                                                            
 Dementia Discovery Fund (DDF)
                                                                                
                                                                            
 Mission BioCapital
                                                                                
 LS Polaris Innovation Fund
                                                                                
 ALS Investment Fund
                                                                                
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)